Al Hammadi Company for Development and Investment’s fully-owned subsidiary was awarded on Dec. 5 a SAR 20 million deal to supply vaccines to the Ministry of Health, the firm said in a statement to Tadawul.
The final contract is expected to be signed on March, 31, 2019.
The deal has no related parties, and its financial impact is likely to show on Q1 2019 results, the firm said.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}